CAS 152684-53-2

L-Glutamyl-S-(benzyl)-L-cysteinyl-D-phenylglycine

Description:

L-Glutamyl-S-(benzyl)-L-cysteinyl-D-phenylglycine, with the CAS number 152684-53-2, is a synthetic peptide that exhibits characteristics typical of peptide compounds. It is composed of amino acids, which are the building blocks of proteins, and features a specific sequence that includes L-glutamic acid, L-cysteine, and D-phenylglycine. This compound may possess unique biological activities due to its structural configuration, potentially influencing its interactions with biological receptors or enzymes. Peptides like this one are often studied for their roles in various biochemical processes, including signaling pathways and enzyme inhibition. The presence of a benzyl group in the cysteine residue may enhance its hydrophobic properties, potentially affecting its solubility and stability in biological systems. Additionally, the stereochemistry of the amino acids can significantly impact the compound's biological activity and pharmacokinetics. Overall, L-Glutamyl-S-(benzyl)-L-cysteinyl-D-phenylglycine represents a complex structure that may have applications in medicinal chemistry and biochemistry.

Formula: C₂₃H₂₇N₃O₆S

TLK117

CAS: 152684-53-2

TLK117

Purity: ≥98%

Molecular weight: 473.54g/mol

Ref: 54-BUP21877

TLK117

CAS: 152684-53-2

TLK117 is an inhibitor of GSTs that reduces the severity of pulmonary fibrosis and may be used in the study of idiopathic pulmonary fibrosis.

Formula: C₂₃H₂₇N₃O₆S

Purity: 99.89%

Color and Shape: Solid

Molecular weight: 473.54

Ref: TM-T8424

TLK117

CAS: 152684-53-2

TLK117 is a potent inhibitor of kinase, a protein that plays a crucial role in cancer cell growth and proliferation. This human oxytocin analog has been shown to induce apoptosis, or programmed cell death, in tumor cells. TLK117 is an anticancer drug that has demonstrated significant efficacy against various types of cancer in preclinical studies. It is particularly effective against Chinese hamster ovary cells and caffeine-treated urine cells. TLK117 works by inhibiting the activity of kinase, which leads to the suppression of cancer cell growth and proliferation. This inhibitor shows great promise as a novel therapeutic option for the treatment of cancer.

Formula: C₂₃H₂₇N₃O₆S

Purity: Min. 95%

Molecular weight: 473.5 g/mol

Ref: 3D-CGA68453